Ameriflex Group, Inc. Novavax Inc Transaction History
Ameriflex Group, Inc.
- $190 Billion
- Q2 2025
A detailed history of Ameriflex Group, Inc. transactions in Novavax Inc stock. As of the latest transaction made, Ameriflex Group, Inc. holds 2,000 shares of NVAX stock, worth $17,780. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,000
Previous 2,000
-0.0%
Holding current value
$17,780
Previous $12.8 Million
1.4%
% of portfolio
0.01%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding NVAX
# of Institutions
314Shares Held
94.7MCall Options Held
6.11MPut Options Held
10.5M-
Vanguard Group Inc Valley Forge, PA15.4MShares$137 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.8MShares$105 Million0.0% of portfolio
-
Shah Capital Management11.5MShares$102 Million35.13% of portfolio
-
State Street Corp Boston, MA6.82MShares$60.7 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY3.94MShares$35 Million0.02% of portfolio
About NOVAVAX INC
- Ticker NVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,215,104
- Market Cap $695M
- Description
- Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...